1. Expression signature of ten genes predicts the survival of patients with estrogen receptor positive‑breast cancer that were treated with tamoxifen
    He Huang et al, 2018, Oncology Letters CrossRef
  2. Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target
    Shuo Qie et al, 2022, Journal of Experimental & Clinical Cancer Research CrossRef
  3. Circulating tumor cells in gastric cancer: developments and clinical applications
    Qian Deng et al, 2023, Clinical and Experimental Medicine CrossRef
  4. MicroRNA-206 suppresses gastric cancer cell growth and metastasis
    Jun Ren et al, 2014, Cell & Bioscience CrossRef
  5. MiR-184 Retarded the Proliferation, Invasiveness and Migration of Glioblastoma Cells by Repressing Stanniocalcin-2
    Linsen Feng et al, 2018, Pathology & Oncology Research CrossRef
  6. STC2 Is a Potential Prognostic Biomarker for Pancreatic Cancer and Promotes Migration and Invasion by Inducing Epithelial–Mesenchymal Transition
    Chen Lin et al, 2019, BioMed Research International CrossRef
  7. Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer
    Yi‐Nan Liu et al, 2019, International Journal of Cancer CrossRef
  8. Stanniocalcin 2 promotes cell proliferation and cisplatin resistance in cervical cancer
    Yuxia Wang et al, 2015, Biochemical and Biophysical Research Communications CrossRef
  9. 3D Culture Modeling of Metastatic Breast Cancer Cells in Additive Manufactured Scaffolds
    Afroditi Nanou et al, 2022, ACS Applied Materials & Interfaces CrossRef
  10. Circulating Tumor Cells (CTCs) Detected by RT-PCR and Its Prognostic Role in Gastric Cancer: A Meta-Analysis of Published Literature
    Shuyi Wang et al, 2014, PLoS ONE CrossRef
  11. Prognostic value of high stanniocalcin 2 expression in solid cancers
    Lixia Hu et al, 2019, Medicine CrossRef
  12. Stanniocalcin2 acts as an anorectic factor through activation of STAT3 pathway
    Yang Jiao et al, 2017, Oncotarget CrossRef
  13. A prognostic long non-coding RNA-associated competing endogenous RNA network in head and neck squamous cell carcinoma
    Chengyao Zhang et al, 2020, PeerJ CrossRef
  14. Effect of STC2 gene silencing on colorectal cancer cells
    Qianyuan Li et al, 2019, Molecular Medicine Reports CrossRef
  15. STC2 is a potential biomarker of hepatocellular carcinoma with its expression being upregulated in Nrf1α-deficient cells, but downregulated in Nrf2-deficient cells
    Qiqi Bu et al, 2023, International Journal of Biological Macromolecules CrossRef
  16. Meta-analysis shows that circulating tumor cells including circulating microRNAs are useful to predict the survival of patients with gastric cancer
    Zhen-yu Zhang et al, 2014, BMC Cancer CrossRef
  17. Stanniocalcin 2 improved osteoblast differentiation via phosphorylation of ERK
    Juan Zhou et al, 2016, Molecular Medicine Reports CrossRef
  18. Clinical significance of circulating tumor cells in blood from patients with gastric cancer
    Takaaki Arigami et al, 2017, Annals of Gastroenterological Surgery CrossRef
  19. Serum Follistatin Is Increased in Thyroid Cancer and Is Associated With Adverse Tumor Characteristics in Humans
    Grigorios Panagiotou et al, 2021, The Journal of Clinical Endocrinology & Metabolism CrossRef
  20. Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer
    Camilla Coulson‐Gilmer et al, 2018, The Journal of Pathology: Clinical Research CrossRef
  21. A gene expression-based risk model reveals prognosis of gastric cancer
    Xiaorong Deng et al, 2018, PeerJ CrossRef
  22. New Insights Into Physiological and Pathophysiological Functions of Stanniocalcin 2
    Aditya D. Joshi, 2020, Frontiers in Endocrinology CrossRef
  23. The significance of Stanniocalcin 2 in malignancies and mechanisms
    Shasha Li et al, 2021, Bioengineered CrossRef
  24. Stanniocalcin 2 Ameliorates Hepatosteatosis Through Activation of STAT3 Signaling
    Jiejie Zhao et al, 2018, Frontiers in Physiology CrossRef
  25. Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma
    ZHEN-HAI ZHANG et al, 2014, Oncology Letters CrossRef
  26. Comprehensive molecular exploration identified promoter DNA methylation of the CRBP1 gene as a determinant of radiation sensitivity in rectal cancer
    K Yokoi et al, 2017, British Journal of Cancer CrossRef
  27. Stanniocalcin-2 May Be a Potentially Valuable Prognostic Marker in Endometrial Cancer: a Preliminary Study
    Hulya Ayik Aydin et al, 2019, Pathology & Oncology Research CrossRef